Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

China flag China · Delayed Price · Currency is CNY
1.520
-0.050 (-3.18%)
May 21, 2026, 3:00 PM CST
Market Cap21.02B -24.9%
Revenue (ttm)5.03B -4.8%
Net Income-14.74M
EPS-0.00
Shares Out13.83B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume203,355,249
Average Volume144,487,012
Open1.560
Previous Close1.570
Day's Range1.510 - 1.580
52-Week Range1.520 - 2.270
Beta0.76
RSI16.46
Earnings DateAug 21, 2026

About Kangmei Pharmaceutical

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China. [Read more]

Sector Healthcare
Founded 1997
Employees 4,233
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600518
Full Company Profile

Financial Performance

In 2025, Kangmei Pharmaceutical's revenue was 5.25 billion, an increase of 1.22% compared to the previous year's 5.19 billion. Earnings were 10.33 million, an increase of 20.46%.

Financial Statements